36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
18 °P sammeln
  • Broschiertes Buch

Colorectal cancer is the fourth most frequently diagnosed cancer and the second leading cause of death in the United states.The incidence of rectal cancer in younger than 50 years has been increasing and is clinically, pathologically and genetically different in such age group. Well assessment of rectal cancer patients before selection type of therapy is very critical to select whom patient will benefit from NACRT, gain functional preservation at time of surgery and raise the probability of overall survival.

Produktbeschreibung
Colorectal cancer is the fourth most frequently diagnosed cancer and the second leading cause of death in the United states.The incidence of rectal cancer in younger than 50 years has been increasing and is clinically, pathologically and genetically different in such age group. Well assessment of rectal cancer patients before selection type of therapy is very critical to select whom patient will benefit from NACRT, gain functional preservation at time of surgery and raise the probability of overall survival.
Autorenporträt
Wafaa A. Elnemrawy, MB.B.CH: studied medicine at Tanta University. Finished the first part of Master degree at Ain Shams University. American Heart Association member as Health Care Provider since March, 2016. Sub investigator in two trials related to mosothelioma and NSCLC in Nasser institute for treatment and research.